How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

430 results for

Fetal Foot Measurement

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. A revisit of the fetal foot length and fetal measurements in early pregnancy sonography Full Text available with Trip Pro

A revisit of the fetal foot length and fetal measurements in early pregnancy sonography To present the fetal measurements in relation to the foot length at 10-16 weeks gestation on antenatal ultrasound.We reviewed the fetal measurements in 47 scans performed at 10-16 weeks gestation in women attending routine antenatal care. The fetal measurements and measurement ratios were examined in relation to the foot length.The fetal biparietal diameter, head circumference, abdominal circumference, femur (...) of the gestational age in early pregnancy. Compared with crown rump length, the correlation between foot length and other fetal measurements is better. The fetal measurements ratios are gestational age dependent between 10-16 weeks. Gestational age specific ratio should be used in this period.

2017 International journal of women's health

2. Fetal Foot Measurement

Fetal Foot Measurement Fetal Foot Measurement Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Fetal Foot Measurement Fetal Foot (...) Measurement Aka: Fetal Foot Measurement From Related Chapters II. Indications dating demise dating Most accurate method for dating III. Fetal Foot Measurements Week 8.5: Length: 3 mm Week 9.0: Length: 4 mm Week 9.5: Length: 5 mm Week 10.0: Length: 6 mm Week 11.0: Length: 7-8 mm Week 12.0: Length: 9 mm Week 13.0: Length: 11 mm Week 14.0: Length: 14 mm Week 15.0: Length: 18 mm Week 16.0: Length: 20 mm Week 17.0: Length: 23 mm Week 18.0: Length: 26 mm Week 19.0: Length: 29 mm Week 20.0: Length: 33 mm Week

2018 FP Notebook

3. Guidelines on autopsy practice: Fetal autopsy (2nd trimester fetal loss and termination of pregnancy for congenital anomaly)

. · Photography recommended in all cases, essential to document external and internal abnormalities. Digital photography and secure storage preferred. · Routine external body measurements (body weight, crown-rump length, crown-heel length, foot length, occipito-frontal circumference) · Detailed external examination, including: muscle bulk, maceration, local/generalised oedema, pallor, dysmorphic features, assessment of patency of orifices (including choanae) and palatal fusion, limbs, hands and feet (...) Guidelines on autopsy practice: Fetal autopsy (2nd trimester fetal loss and termination of pregnancy for congenital anomaly) CEff 150617 1 FINAL Guidelines on autopsy practice: Fetal autopsy (2 nd trimester fetal loss and termination of pregnancy for congenital anomaly) June 2017 Series authors: Dr Michael Osborn, Imperial College Healthcare NHS Trust Professor Jim Lowe, Nottingham University Hospitals NHS Trust Specialist authors: Dr Phillip Cox, Birmingham Women s Hospital NHS Foundation

2017 Royal College of Pathologists

4. Fetal Foot Measurement

Fetal Foot Measurement Fetal Foot Measurement Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Fetal Foot Measurement Fetal Foot (...) Measurement Aka: Fetal Foot Measurement From Related Chapters II. Indications dating demise dating Most accurate method for dating III. Fetal Foot Measurements Week 8.5: Length: 3 mm Week 9.0: Length: 4 mm Week 9.5: Length: 5 mm Week 10.0: Length: 6 mm Week 11.0: Length: 7-8 mm Week 12.0: Length: 9 mm Week 13.0: Length: 11 mm Week 14.0: Length: 14 mm Week 15.0: Length: 18 mm Week 16.0: Length: 20 mm Week 17.0: Length: 23 mm Week 18.0: Length: 26 mm Week 19.0: Length: 29 mm Week 20.0: Length: 33 mm Week

2015 FP Notebook

5. Measurement of Blood Pressure in Humans Full Text available with Trip Pro

Measurement of Blood Pressure in Humans Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association | Hypertension Search Hello Guest! Login to your account Email Password Keep me logged in Search May 2019 April 2019 March 2019 February 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Measurement of Blood Pressure in Humans (...) May 2019 Hypertension. 2019;73:e35–e66 Abstract The accurate measurement of blood pressure (BP) is essential for the diagnosis and management of hypertension. This article provides an updated American Heart Association scientific statement on BP measurement in humans. In the office setting, many oscillometric devices have been validated that allow accurate BP measurement while reducing human errors associated with the auscultatory approach. Fully automated oscillometric devices capable of taking

2019 American Heart Association

6. Postnatal Foot Length to Determine Gestational Age: A Pilot Study Full Text available with Trip Pro

Postnatal Foot Length to Determine Gestational Age: A Pilot Study Gestational age is a critical factor in the management, decision-making, prognostication and follow-up of newborn infants. It is also essential for research and epidemiology. In the absence of an early assessment of fetal gestation by abdominal ultrasound, many neonatal units in developing countries determine gestational age by neonatal scores and last menstrual period-both of which are highly inaccurate. The aim of this pilot (...) study was to determine whether postnatal foot length measurement could accurately determine gestational age in a specified South African hospitalized neonatal population. Foot length was measured with a plastic Verniere's caliper. Foot length was shown to correlate well with gestational age (r = 0.919,p < 0.001). Intra-observer and inter-observer variability of foot length measurements was low. Foot length can therefore be used with high accuracy to determine the gestational age in a population

2016 Journal of tropical pediatrics

7. Late Intrauterine Fetal Death and Stillbirth

contraindicated if parents ? external do not wish (written consent essential) ? autopsy External examination should include ? microscopy weight and length measurement ? X-ray ? placenta and cord IUGR is a significant association for late IUFD Some tests should be taken before birth. Tests below the bold line are fetal. Shaded tests are selective. AV = atrioventricular; CMV = cytomegalovirus; CRP = C-reactive protein; DIC = disseminated intravascular coagulation; FT3 = free triiodothyronine; FT4 = free (...) Late Intrauterine Fetal Death and Stillbirth Late Intrauterine Fetal Death and Stillbirth Green–top Guideline No. 55 October 2010RCOG Green-top Guideline No. 55 2 of 33 © Royal College of Obstetricians and Gynaecologists Late Intrauterine Fetal Death and Stillbirth This is the first edition of this guideline. 1. Purpose and scope To identify evidence-based options for women (and their relatives) who have a late intrauterine fetal death (IUFD: after 24 completed weeks of pregnancy

2010 Royal College of Obstetricians and Gynaecologists

8. NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers

NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. NEOX® CORD 1K vs (...) Standard of Care in Non-healing Diabetic Foot Ulcers (CONDUCT I) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02166294 Recruitment Status : Terminated (Sponsor decision) First Posted : June 18, 2014 Last Update Posted : June 27, 2017 Sponsor: Amniox Medical, Inc. Information provided by (Responsible

2014 Clinical Trials

9. Cerebral palsy in under 25s: assessment and management

, particularly outside the home. 1.8.10 Advise parents or carers that intra-oral devices have not been shown to improve eating, drinking and swallowing in children and young people with cerebral palsy. 1.8.11 Use outcome measures important to the child or young person and their parents or carers to review: Cerebral palsy in under 25s: assessment and management (NG62) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 18 (...) and management (NG62) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 20 of 461.10 Optimising nutritional status 1.10.1 Regularly review the nutritional status of children and young people with cerebral palsy, including measuring their height and weight (or consider alternative anthropometric measurements, particularly if height and weight cannot be measured). 1.10.2 Provide timely access to assessment and nutritional

2017 National Institute for Health and Clinical Excellence - Clinical Guidelines

10. Guidelines For Professional Ultrasound Practice

Practice. Revision 3, December 2018 Minor amendments, March 2019. 3 2.12.1 Shoulder 97 2.12.2 Elbow 101 2.12.3 Wrist and hand 104 2.12.4 Hip 106 2.12.5 Knee 107 2.12.6 Foot and Ankle 109 2.12.7 Rheumatology Ultrasound Examinations 112 2. 13 ELASTOGRAPHY 122 2.14 CONTRAST ENHANCED ULTRASOUND (CEUS) 124 2.15 INTERVENTIONAL AND ‘EXTENDED SCOPE’ EXAMINATIONS (SONOGRAPHERS) 127 2.16 PATIENT GROUP DIRECTIONS 127 2.17 ACQUISITION, ARCHIVING AND USE OF ULTRASOUND DATA 130 2.18 AUDIT AND LEARNING FROM (...) by an evidence base and are effectively measurable’. Guideline: ‘A general rule, principle or piece of advice. Guidelines provide recommendations on how ultrasound examinations should be performed and are based on best available evidence. They help ultrasound practitioners in their work but they do not replace their knowledge and skills’. Protocol: An agreement, preferably based on research, between practitioners to ensure the delivery of high quality standardised ultrasound examinations. The title

2019 British Medical Ultrasound Society

11. ESC/ESH Management of Arterial Hypertension Full Text available with Trip Pro

= transient ischaemic attack; PAD = peripheral artery disease; SCORE = Systematic COronary Risk Evaluation. Table 6 Risk modifiers increasing cardiovascular risk estimated by the Systemic COronary Risk Evaluation (SCORE) system Social deprivation, the origin of many causes of CVD Obesity (measured by BMI) and central obesity (measured by waist circumference) Physical inactivity Psychosocial stress, including vital exhaustion Family history of premature CVD (occurring at age <55 years in men and <60 years (...) in women) Autoimmune and other inflammatory disorders Major psychiatric disorders Treatment for infection with human immunodeficiency virus Atrial fibrillation LV hypertrophy CKD Obstructive sleep apnoea syndrome Social deprivation, the origin of many causes of CVD Obesity (measured by BMI) and central obesity (measured by waist circumference) Physical inactivity Psychosocial stress, including vital exhaustion Family history of premature CVD (occurring at age <55 years in men and <60 years in women

2018 European Society of Cardiology

12. Ertugliflozin l-pyroglutamic acid / metformin hydrochloride (Segluromet) - Diabetes Mellitus, Type 2

were measured in the urinary bladder, liver, kidney medulla, and kidney. The radioactivity did not show affinity for pigmented tissues containing melanin and exposure in the non­circumventricular CNS tissues was lower than blood concentrations (Tissue­to­blood ratio = 0.047 to 0.094 for Cmax and 0.064 to 0.12 for AUClast). Placental transfer of radioactivity was widespread with exposures to most fetal tissues, amniotic sac, amniotic fluid, myometrium, and placenta. Highest concentration (...) under the curve AUCinf area under the concentration-time curve from 0 to infinity AUClast area under the concentration –time curve from zero to time of last measurable concentration BCS biopharmaceutical classification system bid twice daily BMD bone mineral density BMI body mass index Broad pool pooled safety data from all seven ertugliflozin phase III studies BUN blood urea nitrogen CFU colony forming units CHMP Committee for Medicinal Products for Human use CI confidence interval cLDA constrained

2018 European Medicines Agency - EPARs

13. Ertugliflozin l-pyroglutamic acid (Steglatro) - Diabetes Mellitus, Type 2

’ own tests and studies and/or bibliographic literature substituting/supporting certain tests or studies. Information on Paediatric requirements Pursuant to Article 7 of Regulation (EC) No 1901/2006, the application included an EMA Decision(s) P/0214/2014 on the agreement of a paediatric investigation plan (PIP) and on the granting of a deferral and on the granting of a waiver for ertugliflozin. At the time of submission of the application, the PIP P/0214/2014 was not yet completed as some measures (...) -dose toxicity studies in mice (28-day and 3-month), rats (4-week, 3-, 6-month) and dogs (1-, 3-, 9-month), in fertility and embryonic development study in rats, in embryo-fetal development studies in rats and rabbits, in pre- and postnatal development study in rats, in juvenile toxicity studies in rats, in genotoxicology and carcinogenicity studies in mice and rats. All pivotal safety pharmacological and toxicology studies were conducted according to European guidelines and GLP. 2.3.2. Pharmacology

2018 European Medicines Agency - EPARs

14. Ertugliflozin l-pyroglutamic acid / sitagliptin phosphate monohydrate (Steglujan) - Diabetes Mellitus, Type 2

: Figure 2: Sitagliptin active substance structure The chemical structure of sitagliptin phosphate was elucidated by a combination of UV, IR, MS, 1H- NMR, 13C- NMR. The solid state properties of the active substance were measured by X-ray crystallography. Sitagliptin phosphate monohydrate is a white to off-white powder, non-hygroscopic and soluble in water. Sitagliptin phosphate monohydrate is the subject of a Ph. Eur. monograph (2778). Sitagliptin phosphate exhibits stereoisomerism due to the presence (...) for single-dose pharmacokinetic studies. Quantitative whole body autoradiography (QWBA), liquid scintillation counting and HPLC coupled to radiometric detection were used to measure [ 14 C]ertugliflozin-derived radioactivity. Absorption Ertugliflozin was well absorbed and demonstrated low to moderate clearance (1.6 – 14 mL/min/kg) with a moderate volume of distribution (0.8 – 1.6 L/kg) in the nonclinical species evaluated. Mean apparent terminal half-life (t½) values for ertugliflozin ranged from

2018 European Medicines Agency - EPARs

15. Guidelines For Professional Ultrasound Practice

and neonatal liver and biliary system (including pancreas and spleen) 70 2.11.2 Paediatric urinary system 74 2.11.3 Paediatric gastro-intestinal tract 75 2.11.4 Neonatal hip 76 2.11.5 Neonatal intracranial ultrasound 77 2.12 Musculoskeletal ultrasound examinations 78 Examination specific guidelines and common scenarios 2.12.1 Shoulder 78 2.12.2 Elbow 84 2.12.3 Wrist and hand 88 2.12.4 Hip 91 2.12.5 Knee 94 2.12.6 Foot and ankle 97 2.12.7 Rheumatology ultrasound examinations 101 2.13 Elastography 111 2.14 (...) of Radiographers (SCoR) document. Standard: ‘A required or agreed level of quality or attainment. A standard is a way of ensuring optimum levels of care or service delivery. Standards promote the likelihood of an ultrasound examination being delivered safely and effectively, are clear about what needs to be done to comply, are informed by an evidence base and are effectively measureable’. Guideline: ‘A general rule, principle or piece of advice. Guidelines provide recommendations on how ultrasound examinations

2018 British Medical Ultrasound Society

16. Ocrelizumab (Ocrevus) - multiple sclerosis

Units F/T Freeze/Thaw; Assessment report EMA/790835/2017 Page 5/180 Fab Antigen Binding Portion Of Immunoglobulin Molecule FBS Fetal Bovine Serum Fc Fragment crystallisable Fc?RIIIa Fc gamma receptor IIIa FcRn neonatal Fc receptor FTIR Fourier Transform Infrared Spectroscopy FVIP filtered viral inactivation pool GPMF Genentech Production Manufacturing Facility HC Heavy Chain; HCCF Harvested Cell Culture Fluid HCP Host Cell Protein HEPES 4-(2-hydroxyethyl)-1-piperazine ethane sulfonic acid HMWS High (...) ATA anti-therapeutic antibody AUC area under the concentration-time curve AUC last area under the concentration-time curve from time 0 to the last measurable concentration AUC inf area under the concentration-time curve from time 0 to infinity AUC t area under the concentration-time curve within a dosing interval BCC basal cell carcinoma BLA Biologics License Application BLQ below the limit of quantification BMI body mass index BSA body surface area CCOD clinical cut-off date CDC complement

2018 European Medicines Agency - EPARs

17. Stillbirth care

. For permissions beyond the scope of this licence, contact: Intellectual Property Officer, Queensland Health, GPO Box 48, Brisbane Qld 4001, email ip_officer@health.qld.gov.au, phone (07) 3234 1479. Queensland Clinical Guideline: Stillbirth care Refer to online version, destroy printed copies after use Page 3 of 34 Flow Chart: Stillbirth care Abbreviations: CTG: Cardiotocograph; FGR: fetal growth restriction; GP: General Practitioner; PPM: Private Practice Midwife; PSANZ: Perinatal Society of Australia and New (...) referrals · Complete documentation Communication Labour and birth Consider birthing options · Discuss timing and options for birth with parents–provide written information · Vaginal birth is generally preferable · Consider method of induction relevant to gestation and clinical circumstances (especially obstetric surgical history) · Ensure adequate analgesia · Consider active third stage management Antenatal Diagnosis of fetal death · Diagnose with USS Investigations of fetal death · Refer to Flowchart

2019 Queensland Health

18. Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures

been criticized as an insensitive marker of disease, it currently provides the most useful population-level measurement of overweight and obesity, and its utility as an estimate of risk has been validated in multiple large population studies across multiple continents. The j-shaped curve for BMI and mortality has recently been confirmed in a large meta-analysis (9) and a systematic review (10) that included 10.6 million and 30 million participants, respectively. These DOI:10.4158/GL-2019-0406 © (...) /files/lipid-guidelines.pdf and www.lipid.org/recommendations) (Grade D). R17. (2013*). Candidates for bariatric procedures should avoid pregnancy pre- procedure and for 12 to 18 months post-procedure (Grade D). Women who become pregnant after bariatric procedures should be counseled and monitored for appropriate weight gain, nutritional supplementation, and fetal health (Grade C; BEL 3). All women DOI:10.4158/GL-2019-0406 © 2019 AACE. 30 of reproductive age should be counseled on contraceptive

2019 American Association of Clinical Endocrinologists

19. Pruritus

types of CP may lead to a significant improvement [e.g. therapy of polycythemia vera- associated aquagenic pruritus with janus kinase (JAK) inhibitors]. Still, there is a significant lack of randomised controlled trials (RCTs) investigating different types of CP in detail, which can be explained by the diversity and complexity of this symptom, the multifactorial aetiologies of pruritus and the lack of well-defined outcome measures, biomarkers and therapy targets. To complicate matters, RCTs exist (...) (Lewis-Jones and Finlay 1995) and ItchyQoL (Desai, Poindexter et al. 2008). Instruments that measure the effect of the families' quality of life include the dermatitis family impact questionnaire (Lawson, Lewis-Jones et al. 1998). The course of advanced learning for the management of itch (CALM-IT) task force recommend a multidisciplinary and multidimensional approach for children CP (Metz, Wahn et al. 2013). It must be assumed that systemic causes of CP in children are mostly based on genetic

2019 European Dermatology Forum

20. Heart Disease and Stroke Statistics Full Text available with Trip Pro

analyses, lower socioeconomic status was associated with a 12% higher risk for amputation. In 2017, the Centers for Medicare & Medicaid Services decided to cover supervised exercise therapy (up to 36 sessions over 12 weeks) for eligible symptomatic peripheral artery disease patients with intermittent claudication. Quality of Care (Chapter 24) Quality and performance measures for MI have been relatively stable in recent years but have improved longitudinally since data collection began. Among hospitals (...) is based on the Rose Questionnaire; estimates are made regularly for HF; hypertension is based on BP measurements and interviews; and an estimate can be made for total CVD, including MI, AP, HF, stroke, and hypertension. A major emphasis of this Statistical Update is to present the latest estimates of the number of people in the United States who have specific conditions to provide a realistic estimate of burden. Most estimates based on NHANES prevalence rates are based on data collected from 2013

2019 American Heart Association

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>